|
|
|
|
|
by Nursie
4945 days ago
|
|
The issue here has to be that it's hard to mask MDMA - people are going to know they're on something even at therapeutic (rather than recreational) doses, are they not? Is that really poor blinding? Antidepressants tend to be long lasting and slow acting (AFAICT) which MDMA is not. |
|
Regarding the issue of whether or not it is poor blinding, I guess it is a bit like the tree falling in the forest but nobody is around to hear it: if you conduct a placebo-controlled study, but all the participants can correctly guess which group they're in, is it really a placebo-controlled study?